Two years of tamoxifen followed by 3 years of anastrozole versus 5 years of tamoxifen alone in postmenopausal women with hormone-responsive early breast cancer: Efficacy results from 3,714 patients from the Austrian Breast and Colorectal Cancer Study Group (ABCSG) trial 8.
2010 ◽
Vol 28
(15_suppl)
◽
pp. 534-534
Keyword(s):
Keyword(s):
2010 ◽
Keyword(s):
2013 ◽
Keyword(s):
2009 ◽
Vol 121
(1)
◽
pp. 211-218
◽
2007 ◽
Vol 16
(1)
◽
pp. 67-74
◽
2007 ◽
Vol 43
(11)
◽
pp. 1646-1653
◽
Keyword(s):
2009 ◽
Vol 45
(4)
◽
pp. 561-571
◽
Keyword(s):
2008 ◽
Vol 116
(3)
◽
pp. 491-500
◽